Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CHLOROQUINE PH 250 MG TABLET

Chloroquine Phosphate
$2.6029per EA

Strength

250 mg/1

Manufacturer

Rising Pharma Holdings Inc.

NDC

64980017750

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CHLOROQUINE PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091621

On Market Since

7/1/2011

Pharmacological Classes

Antimalarial

Price History

1W

0.0%

1M

+5.1%

3M

+16.6%

6M

+4.1%

1Y

+1.2%

3Y

+176.4%

5Y

+176.4%

All

+200.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

HYDROXYCHLOROQUINE 200 MG TAB
Generic
00093240101•Teva Pharmaceuticals USA Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704606•Major Pharmaceuticals
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704661•Major Pharmaceuticals
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011201•Rising Pharma Holdings Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011250•Rising Pharma Holdings Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011001•NorthStar Rx LLC
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011002•NorthStar Rx LLC
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048501•Accord Healthcare Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048516•Accord Healthcare Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
43598072101•Dr. Reddy's Laboratories Inc.
$0.1622
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy